{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:52:23Z","timestamp":1791834743960,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":3619,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1111\/j.1469-0691.2004.01036.x","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T10:37:38Z","timestamp":1105439858000},"page":"39-46","source":"Crossref","is-referenced-by-count":25,"title":["Surveillance of linezolid resistance in Germany, 2001\u20132002"],"prefix":"10.1016","volume":"11","author":[{"given":"J.","family":"Brauers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kresken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl A","key":"10.1111\/j.1469-0691.2004.01036.x_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/39.suppl_1.1","article-title":"Gram-positive resistance: challenge for the development of new antibiotics","volume":"39","author":"Baquero","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2004.01036.x_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-199600511-00004","article-title":"Emerging resistance to antimicrobial agents in gram-positive bacteria: enterococci, staphylococci and non-pneumococcal streptococci","volume":"51","author":"Cormican","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib4","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin-United States, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib5","first-page":"902","article-title":"Public health dispatch: vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/jmbi.1999.3247","article-title":"Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center","volume":"294","author":"Kloss","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/45.6.797","article-title":"Activity of linezolid against gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors","volume":"45","author":"Fines","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/46.6.931","article-title":"Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid","volume":"46","author":"Henwood","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0732-8893(99)00016-4","article-title":"In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae","volume":"34","author":"Patel","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/48.1.47","article-title":"Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison","volume":"48","author":"Gemmel","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1469-0691.2002.00484.x","article-title":"Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvoxy\u00ae antimicrobial potency study (ZAPS-Europe)","volume":"8","author":"Bolmstrom","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1469-0691.2002.00455.x","article-title":"Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae","volume":"8","author":"Fr\u00e9d\u00e9nucci","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"suppl S2","key":"10.1111\/j.1469-0691.2004.01036.x_bib14","first-page":"27","article-title":"Efficacy of linezolid versus comparator therapies in gram-positive infections","volume":"51","author":"Wilcox","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib15","series-title":"Methoden zur Empfindlichkeitspr\u00fcfung von bakteriellen Krankheitserregern (au\u00dfer Mykobakterien) gegen Chemotherapeutika. Mikrodilution","author":"Deutsches Institut f\u00fcr Normung (DIN)","year":"1990"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib16","series-title":"Methoden zur Empfindlichkeitspr\u00fcfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika. Teil 4: Bewertungsstufen der minimalen Hemmkonzentration MHK-Grenzwerte von antibakteriellen Wirkstoffen","author":"Deutsches Institut f\u00fcr Normung (DIN)","year":"2000"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib17","volume":"vol. 20","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib18","volume":"vol. 22","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1055\/s-2002-35463","article-title":"Epidemiologie von Septik\u00e4mie-Erregern","volume":"127","author":"Rosenthal","year":"2002","journal-title":"Deutsche Med Wochenschr"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/49.1.61","article-title":"Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany","volume":"49","author":"Reinert","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib21","series-title":"Methoden zur Empfindlichkeitspr\u00fcfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika. Teil 3: Agardiffusionstest. Angaben f\u00fcr die Bewertung der Hemmhofdurchmesser","author":"Deutsches Institut f\u00fcr Normung (DIN)","year":"2000"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JCM.36.4.1020-1027.1998","article-title":"Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides","volume":"36","author":"Tenover","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/jac\/41.5.578","article-title":"Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus","volume":"41","author":"Fitch","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jac\/dkh113","article-title":"BSAC standardized disc susceptibility testing method (version 3)","volume":"53","author":"Andrews","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/46.6.931","article-title":"Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid","volume":"46","author":"Henwood","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1198-743x.2001.00305.x","article-title":"The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands","volume":"7","author":"Mouton","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jac\/48.6.932","article-title":"In vitro activity of linezolid against gram-positive cocci isolated in Poland","volume":"48","author":"Szczypa","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1469-0691.2002.00429.x","article-title":"Comparative activity of linezolid against staphylococci and enterococci isolated in Italy","volume":"8","author":"Stefani","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0732-8893(01)00334-0","article-title":"A multicenter evaluation of linezolid antimicrobial activity in North America","volume":"43","author":"Ballow","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1469-0691.2002.00484.x","article-title":"Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvoxy\u00ae antimicrobial potency study (ZAPS-Europe)","volume":"8","author":"Bolmstrom","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib31","series-title":"Bericht \u00fcber die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitspr\u00fcfungen und Resistenz der Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e. V. aus dem Jahre 2001","author":"Kresken","year":"2003"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib32","first-page":"87","article-title":"In-vitro-Aktivit\u00e4t von Linezolid gegen Staphylococcus species im Vergleich zu anderen Antibiotika","volume":"11","author":"Korn","year":"2002","journal-title":"Chemother J"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/43.4.569","article-title":"Comparative in-vitro-activities of moxifloxacin, trovafloxacin, quinupristin\/dalfopristin and linezolid against staphylococci","volume":"43","author":"Von Eiff","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib34","series-title":"Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"118","article-title":"Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 848]","author":"Zurenko","year":"1999"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.01036.x_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkg104","article-title":"Linezolid resistance in clinical isolates of Staphylococcus aureus","volume":"51","author":"Wilson","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T08:22:50Z","timestamp":1586074970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14621935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1198743X14621935"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.01036.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}